fda glp-1 warning november 2025 The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. https://www.abc27.com/national/compounded-glp-1 -drugs-creating-concern-among-doctors-and-fda/?utm_medium FDA Warns Telehealth Firms Over

Recent studies suggest that these compounds may influence the secretion of various gastrointestinal hormones, including glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), and peptide YY (PYY), while simultaneously reducing ghrelin levels 1

A qualified provider should evaluate your personal timeline expectations based on your medical history, baseline weight, metabolic markers, and prior medication responses

Research published in MDPI demonstrates that L-theanine suppresses the activation of microglia, the brain's primary immune cells

The product has not been evaluated by the FDA for safety or effectiveness

A follow-up study in the same journal examined daytime performance in partially sleep-restricted volunteers who received glycine supplementation

A lot of folks are diagnosed as prediabetes or prediabetic